WM TECHNOLOGY INC (MAPS)

US92971A1097 - Common Stock

0.716  -0.02 (-2.59%)

Premarket: 0.8279 +0.11 (+15.63%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MAPS. MAPS was compared to 279 industry peers in the Software industry. While MAPS seems to be doing ok healthwise, there are quite some concerns on its profitability. MAPS is cheap, but on the other hand it scores bad on growth.



3

1. Profitability

1.1 Basic Checks

MAPS had negative earnings in the past year.
MAPS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MAPS reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: MAPS reported negative operating cash flow in multiple years.

1.2 Ratios

MAPS has a Return On Assets (-3.98%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -27.37%, MAPS is doing worse than 61.65% of the companies in the same industry.
MAPS has a better Return On Invested Capital (9.99%) than 87.81% of its industry peers.
Industry RankSector Rank
ROA -3.98%
ROE -27.37%
ROIC 9.99%
ROA(3y)-15.89%
ROA(5y)-13.47%
ROE(3y)-277.04%
ROE(5y)-171.91%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MAPS has a better Operating Margin (9.70%) than 78.85% of its industry peers.
MAPS has a better Gross Margin (94.24%) than 98.92% of its industry peers.
Industry RankSector Rank
OM 9.7%
PM (TTM) N/A
GM 94.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MAPS is destroying value.
MAPS has more shares outstanding than it did 1 year ago.
MAPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of 1.53, we must say that MAPS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.53, MAPS is doing worse than 60.22% of the companies in the same industry.
There is no outstanding debt for MAPS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.53
ROIC/WACC0.91
WACC10.98%

2.3 Liquidity

A Current Ratio of 1.77 indicates that MAPS should not have too much problems paying its short term obligations.
With a Current ratio value of 1.77, MAPS perfoms like the industry average, outperforming 53.41% of the companies in the same industry.
A Quick Ratio of 1.77 indicates that MAPS should not have too much problems paying its short term obligations.
MAPS's Quick ratio of 1.77 is in line compared to the rest of the industry. MAPS outperforms 53.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.77

2

3. Growth

3.1 Past

MAPS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 93.70%, which is quite impressive.
The Revenue has decreased by -9.68% in the past year.
EPS 1Y (TTM)93.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-9.68%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-9.73%

3.2 Future

The Earnings Per Share is expected to grow by 63.62% on average over the next years. This is a very strong growth
MAPS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.94% yearly.
EPS Next Y189.25%
EPS Next 2Y86.75%
EPS Next 3Y63.62%
EPS Next 5YN/A
Revenue Next Year-8.25%
Revenue Next 2Y0.05%
Revenue Next 3Y5.31%
Revenue Next 5Y5.94%

3.3 Evolution

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MAPS. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 4.01, the valuation of MAPS can be described as very cheap.
Based on the Price/Forward Earnings ratio, MAPS is valued cheaper than 98.57% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.79. MAPS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 4.01

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MAPS indicates a rather cheap valuation: MAPS is cheaper than 98.92% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, MAPS is valued cheaply inside the industry as 98.92% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.25
EV/EBITDA 2.39

4.3 Compensation for Growth

MAPS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MAPS's earnings are expected to grow with 63.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.75%
EPS Next 3Y63.62%

0

5. Dividend

5.1 Amount

MAPS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

WM TECHNOLOGY INC

NASDAQ:MAPS (11/12/2024, 8:16:58 PM)

Premarket: 0.8279 +0.11 (+15.63%)

0.716

-0.02 (-2.59%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap109.14M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.01
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.98%
ROE -27.37%
ROCE
ROIC
ROICexc
ROICexgc
OM 9.7%
PM (TTM) N/A
GM 94.24%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.77
Quick Ratio 1.77
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)93.7%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y189.25%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-9.68%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y